EARLY STAGE FOLLICULAR LYMPHOMA WHO GRADE 1/2 OR 3A

Clinical trials for EARLY STAGE FOLLICULAR LYMPHOMA WHO GRADE 1/2 OR 3A explained in plain language.

Never miss a new study

Get alerted when new EARLY STAGE FOLLICULAR LYMPHOMA WHO GRADE 1/2 OR 3A trials appear

Sign up with your email to follow new studies for EARLY STAGE FOLLICULAR LYMPHOMA WHO GRADE 1/2 OR 3A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a fraction of the usual radiation dose be enough to treat this blood cancer?

Disease control Recruiting now

This study is for people with early-stage follicular lymphoma, a slow-growing blood cancer. It compares a low-dose radiation (4 Gy) plus an antibody drug (obinutuzumab) against the standard higher-dose radiation (24 Gy) plus another antibody (rituximab). The goal is to see if the…

Matched conditions: EARLY STAGE FOLLICULAR LYMPHOMA WHO GRADE 1/2 OR 3A

Phase: PHASE3 • Sponsor: Heidelberg University • Aim: Disease control

Last updated May 15, 2026 11:56 UTC

EARLY STAGE FOLLICULAR LYMPHOMA WHO GRADE 1/2 OR 3A

Get alerted when new EARLY STAGE FOLLICULAR LYMPHOMA WHO GRADE 1/2 OR 3A trials appear

Could a fraction of the usual radiation dose be enough to treat this blood cancer?